These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20388783)

  • 1. Proteomic characterization of novel alternative splice variant proteins in human epidermal growth factor receptor 2/neu-induced breast cancers.
    Menon R; Omenn GS
    Cancer Res; 2010 May; 70(9):3440-9. PubMed ID: 20388783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional implications of structural predictions for alternative splice proteins expressed in Her2/neu-induced breast cancers.
    Menon R; Roy A; Mukherjee S; Belkin S; Zhang Y; Omenn GS
    J Proteome Res; 2011 Dec; 10(12):5503-11. PubMed ID: 22003824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammary tumor formation and metastasis evoked by a HER2 splice variant.
    Alajati A; Sausgruber N; Aceto N; Duss S; Sarret S; Voshol H; Bonenfant D; Bentires-Alj M
    Cancer Res; 2013 Sep; 73(17):5320-7. PubMed ID: 23867476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic characterization of Her2/neu-overexpressing breast cancer cells.
    Chen H; Pimienta G; Gu Y; Sun X; Hu J; Kim MS; Chaerkady R; Gucek M; Cole RN; Sukumar S; Pandey A
    Proteomics; 2010 Nov; 10(21):3800-10. PubMed ID: 20960451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative splice variants, a new class of protein cancer biomarker candidates: findings in pancreatic cancer and breast cancer with systems biology implications.
    Omenn GS; Yocum AK; Menon R
    Dis Markers; 2010; 28(4):241-51. PubMed ID: 20534909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new class of protein cancer biomarker candidates: differentially expressed splice variants of ERBB2 (HER2/neu) and ERBB1 (EGFR) in breast cancer cell lines.
    Omenn GS; Guan Y; Menon R
    J Proteomics; 2014 Jul; 107():103-12. PubMed ID: 24802673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic and PROTEOMEX profiling of mammary cancer progression in a HER-2/neu oncogene-driven animal model system.
    Croci S; Recktenwald CV; Lichtenfels R; Nicoletti G; Dressler SP; De Giovanni C; Astolfi A; Palladini A; Shin-ya K; Landuzzi L; Nanni P; Lollini PL; Seliger B
    Proteomics; 2010 Nov; 10(21):3835-53. PubMed ID: 20957756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel alternative splicing biomarkers for breast cancer with LC/MS/MS and RNA-Seq.
    Zhang F; Deng CK; Wang M; Deng B; Barber R; Huang G
    BMC Bioinformatics; 2020 Dec; 21(Suppl 9):541. PubMed ID: 33272210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer.
    Siegel PM; Ryan ED; Cardiff RD; Muller WJ
    EMBO J; 1999 Apr; 18(8):2149-64. PubMed ID: 10205169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics of breast cancer: enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors.
    Zhang DH; Tai LK; Wong LL; Sethi SK; Koay ES
    Proteomics; 2005 May; 5(7):1797-805. PubMed ID: 15825149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
    Brantley-Sieders DM; Zhuang G; Hicks D; Fang WB; Hwang Y; Cates JM; Coffman K; Jackson D; Bruckheimer E; Muraoka-Cook RS; Chen J
    J Clin Invest; 2008 Jan; 118(1):64-78. PubMed ID: 18079969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel alternative splice isoforms of circulating proteins in a mouse model of human pancreatic cancer.
    Menon R; Zhang Q; Zhang Y; Fermin D; Bardeesy N; DePinho RA; Lu C; Hanash SM; Omenn GS; States DJ
    Cancer Res; 2009 Jan; 69(1):300-9. PubMed ID: 19118015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation.
    Aigner A; Juhl H; Malerczyk C; Tkybusch A; Benz CC; Czubayko F
    Oncogene; 2001 Apr; 20(17):2101-11. PubMed ID: 11360194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splice variants and expression patterns of SHEP1, BCAR3 and NSP1, a gene family involved in integrin and receptor tyrosine kinase signaling.
    Vervoort VS; Roselli S; Oshima RG; Pasquale EB
    Gene; 2007 Apr; 391(1-2):161-70. PubMed ID: 17270363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.
    Whiteaker JR; Zhang H; Zhao L; Wang P; Kelly-Spratt KS; Ivey RG; Piening BD; Feng LC; Kasarda E; Gurley KE; Eng JK; Chodosh LA; Kemp CJ; McIntosh MW; Paulovich AG
    J Proteome Res; 2007 Oct; 6(10):3962-75. PubMed ID: 17711321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of neutrophil gelatinase-associated lipocalin by ErbB2 through nuclear factor-kappaB activation.
    Li SH; Hawthorne VS; Neal CL; Sanghera S; Xu J; Yang J; Guo H; Steeg PS; Yu D
    Cancer Res; 2009 Dec; 69(24):9163-8. PubMed ID: 19951994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer.
    Ruggles KV; Tang Z; Wang X; Grover H; Askenazi M; Teubl J; Cao S; McLellan MD; Clauser KR; Tabb DL; Mertins P; Slebos R; Erdmann-Gilmore P; Li S; Gunawardena HP; Xie L; Liu T; Zhou JY; Sun S; Hoadley KA; Perou CM; Chen X; Davies SR; Maher CA; Kinsinger CR; Rodland KD; Zhang H; Zhang Z; Ding L; Townsend RR; Rodriguez H; Chan D; Smith RD; Liebler DC; Carr SA; Payne S; Ellis MJ; Fenyő D
    Mol Cell Proteomics; 2016 Mar; 15(3):1060-71. PubMed ID: 26631509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective expression of a splice variant of decay-accelerating factor in c-erbB-2-positive mammary carcinoma cells showing increased transendothelial invasiveness.
    Brandt B; Mikesch JH; Simon R; Rötger A; Kemming D; Schier K; Sauter G; Bürger H
    Biochem Biophys Res Commun; 2005 Apr; 329(1):318-23. PubMed ID: 15721309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types.
    Cadieux C; Kedinger V; Yao L; Vadnais C; Drossos M; Paquet M; Nepveu A
    Cancer Res; 2009 Sep; 69(18):7188-97. PubMed ID: 19738070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.